Wells Fargo & Company Second Sight Medical Products Inc Transaction History

Wells Fargo & Company

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.22 - $2.57 $590 - $1,243	-484 Reduced 28.78%	1,198 $2,000
Q1 2022 May 16, 2022	BUY	$1.16 - $1.83 $1 - $1	1 Added 0.06%	1,682 $2,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $3.41 $11 - $23	7 Added 0.42%	1,681 $3,000
Q3 2021 Nov 15, 2021	BUY	$3.11 - $4.75 $183 - $280	59 Added 3.65%	1,674 $6,000
Q2 2021 Aug 16, 2021	SELL	$4.94 - $9.43 $350 - $669	-71 Reduced 4.21%	1,615 $8,000

Q1 2021 May 13, 2021	BUY	$1.43 - $15.48 $2,288 - $24,768	1,600 Added 1860.47%	1,686 $14,000
Q4 2020 Feb 09, 2021	BUY	$0.73 - $3.22 $3 - $16	5 Added 6.17%	86 $0
Q3 2020 Nov 05, 2020	SELL	$0.73 - $1.04 $5 - $8	-8 Reduced 8.99%	81 $0
Q2 2020 Aug 13, 2020	BUY	$0.8 - $2.1 $40 - $107	51 Added 134.21%	89 $0
Q1 2020 May 14, 2020	BUY	$1.0 - $6.05 $38 - $229	38 New	38 $0

Ticker EYES
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 13,136,400
Market Cap $54.4M
Description
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulati...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.